GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
EP0190833B1
(de)
*
|
1985-02-07 |
1991-03-27 |
Takeda Chemical Industries, Ltd. |
Verfahren zur Herstellung von Mikrokapseln
|
JP2551756B2
(ja)
*
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
US4734399A
(en)
*
|
1985-08-06 |
1988-03-29 |
Hoffmann-La Roche Inc. |
Growth hormone releasing factor analogs
|
US5112619A
(en)
*
|
1985-11-12 |
1992-05-12 |
Eli Lilly And Company |
Orally administerable sustained release pharmaceutical formulation
|
EP0225130B1
(de)
*
|
1985-11-22 |
1991-10-30 |
Takeda Chemical Industries, Ltd. |
Liposomzusammensetzung
|
CA1275922C
(en)
*
|
1985-11-28 |
1990-11-06 |
Harunobu Amagase |
Treatment of cancer
|
US4780320A
(en)
*
|
1986-04-29 |
1988-10-25 |
Pharmetrix Corp. |
Controlled release drug delivery system for the periodontal pocket
|
US4832686A
(en)
*
|
1986-06-24 |
1989-05-23 |
Anderson Mark E |
Method for administering interleukin-2
|
JP2526589B2
(ja)
*
|
1986-08-08 |
1996-08-21 |
武田薬品工業株式会社 |
ペプチド含有マイクロカプセルおよびその製造法
|
JPS6341416A
(ja)
*
|
1986-08-08 |
1988-02-22 |
Takeda Chem Ind Ltd |
鎮痛性ペプチド含有マイクロカプセルの製造法
|
JPH0725689B2
(ja)
*
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
CA1321048C
(en)
*
|
1987-03-05 |
1993-08-10 |
Robert W. J. Lencki |
Microspheres and method of producing same
|
US4857335A
(en)
*
|
1987-03-27 |
1989-08-15 |
Lim Technology Laboratories, Inc. |
Liquid controlled release formulations and method of producing same via multiple emulsion process
|
US5500228A
(en)
*
|
1987-05-26 |
1996-03-19 |
American Cyanamid Company |
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
|
US5143661A
(en)
*
|
1987-05-26 |
1992-09-01 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules
|
US4880632A
(en)
*
|
1987-09-08 |
1989-11-14 |
The United States Of America |
Prevention of fescue toxicosis
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
JPH0725649B2
(ja)
*
|
1987-10-12 |
1995-03-22 |
而至歯科工業株式会社 |
消毒剤含有アルギン酸印象材
|
US5187150A
(en)
*
|
1987-10-14 |
1993-02-16 |
Debiopharm S.A. |
Polyester-based composition for the controlled release of polypeptide medicinal substances
|
WO1989003678A1
(en)
*
|
1987-10-30 |
1989-05-05 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
US5051261A
(en)
*
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
US5290562A
(en)
*
|
1987-11-27 |
1994-03-01 |
L V M H Recherche |
Compositions and methods employing liposomes including tyrosine or a tyrosine derivative
|
US5236704A
(en)
*
|
1988-01-28 |
1993-08-17 |
Sumitomo Pharmaceuticals Co., Ltd. |
Controlled release formulation
|
JP2670680B2
(ja)
*
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
US4952408A
(en)
*
|
1988-05-23 |
1990-08-28 |
Georgetown University |
Liposome-encapsulated vinca alkaloids and their use in combatting tumors
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
US5298255A
(en)
*
|
1988-10-28 |
1994-03-29 |
Terumo Kabushiki Kaisha |
Antithrombic medical material, artificial internal organ, and method for production of antithrombic medical material
|
ES2051968T3
(es)
*
|
1988-12-22 |
1994-07-01 |
American Cyanamid Co |
Metodo para el tratamiento de enfermedad periodontal mediante la liberacion continua de un agente terapeutico a la bolsa periodontal; composicion de materia del mismo y aparato para su administracion.
|
US5236355A
(en)
*
|
1988-12-22 |
1993-08-17 |
American Cyanamid Company |
Apparatus for the treatment of periodontal disease
|
US5051305A
(en)
*
|
1988-12-30 |
1991-09-24 |
Arcade, Inc. |
Stabilized perfume-containing microcapsules and method of preparing the same
|
EP0471036B2
(de)
*
|
1989-05-04 |
2004-06-23 |
Southern Research Institute |
Einkapselungsverfahren
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
JP2571874B2
(ja)
*
|
1989-11-06 |
1997-01-16 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
タンパク質マイクロスフェア組成物
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5198220A
(en)
*
|
1989-11-17 |
1993-03-30 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
JP2958103B2
(ja)
*
|
1989-12-12 |
1999-10-06 |
エーザイ株式会社 |
プラズマ照射固形製剤
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
JP2653255B2
(ja)
|
1990-02-13 |
1997-09-17 |
武田薬品工業株式会社 |
長期徐放型マイクロカプセル
|
US5478564A
(en)
*
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
CA2040141C
(en)
*
|
1990-04-13 |
2002-05-14 |
Minoru Yamada |
Biodegradable high-molecular polymers, production and use therof
|
US6517859B1
(en)
|
1990-05-16 |
2003-02-11 |
Southern Research Institute |
Microcapsules for administration of neuroactive agents
|
JP3359919B2
(ja)
*
|
1990-05-16 |
2002-12-24 |
サザン・リサーチ・インスティテュート |
放出制御ドーパミンおよび神経線維成長を刺激するための用途
|
JP3116311B2
(ja)
*
|
1990-06-13 |
2000-12-11 |
エーザイ株式会社 |
マイクロスフィアの製法
|
US5364839A
(en)
*
|
1990-06-18 |
1994-11-15 |
Genetics Institute, Inc. |
Osteoinductive pharmaceutical formulations
|
GB9016885D0
(en)
*
|
1990-08-01 |
1990-09-12 |
Scras |
Sustained release pharmaceutical compositions
|
US5418010A
(en)
*
|
1990-10-05 |
1995-05-23 |
Griffith Laboratories Worldwide, Inc. |
Microencapsulation process
|
KR930006431B1
(ko)
*
|
1990-10-11 |
1993-07-16 |
재단법인 한국화학연구소 |
약물의 미세캡슐화 방법
|
NO302481B1
(no)
*
|
1990-10-16 |
1998-03-09 |
Takeda Chemical Industries Ltd |
Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
|
US5206023A
(en)
*
|
1991-01-31 |
1993-04-27 |
Robert F. Shaw |
Method and compositions for the treatment and repair of defects or lesions in cartilage
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5654009A
(en)
*
|
1991-03-25 |
1997-08-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Delayed action preparation
|
JPH04364131A
(ja)
*
|
1991-04-03 |
1992-12-16 |
Sanwa Kagaku Kenkyusho Co Ltd |
易吸収性モチリン製剤
|
JP3351525B2
(ja)
*
|
1991-06-21 |
2002-11-25 |
ジェネティックス・インスティテュート・インコーポレイテッド |
骨形成性蛋白医薬処方物
|
US5252337A
(en)
*
|
1991-06-25 |
1993-10-12 |
Eurand America, Inc. |
Controlled release calcium channel blocker microcapsules
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5270300A
(en)
*
|
1991-09-06 |
1993-12-14 |
Robert Francis Shaw |
Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
|
DE69220317T2
(de)
*
|
1991-10-01 |
1997-10-16 |
Takeda Chemical Industries Ltd |
Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
|
US5288502A
(en)
*
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
AU3124793A
(en)
*
|
1991-10-29 |
1993-06-07 |
Clover Consolidated, Limited |
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
|
DK0617612T3
(da)
*
|
1991-12-18 |
1998-04-14 |
Warner Lambert Co |
Fremgangsmåde til fremstilling af en fast dispersion
|
US5470582A
(en)
*
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
DE69318835T2
(de)
*
|
1992-04-06 |
1998-11-05 |
Uroplasty Inc |
Behandlung einer refluxstörung durch injektion von mikropartikeln
|
US5922652A
(en)
*
|
1992-05-05 |
1999-07-13 |
Procter & Gamble |
Microencapsulated oil field chemicals
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US20030035845A1
(en)
*
|
1992-06-11 |
2003-02-20 |
Zale Stephen E. |
Composition for sustained release of non-aggregated erythropoietin
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
AU4198793A
(en)
*
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
ES2110573T3
(es)
*
|
1992-08-07 |
1998-02-16 |
Takeda Chemical Industries Ltd |
Produccion de microcapsulas de farmacos solubles en agua.
|
JP3277342B2
(ja)
*
|
1992-09-02 |
2002-04-22 |
武田薬品工業株式会社 |
徐放性マイクロカプセルの製造法
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
WO1994005265A1
(en)
*
|
1992-09-10 |
1994-03-17 |
Children's Medical Center Corporation |
Biodegradable polymer matrices for sustained delivery of local anesthetic agents
|
DE4231493A1
(de)
*
|
1992-09-21 |
1994-03-24 |
Nordmark Arzneimittel Gmbh |
Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat
|
EP0595030A3
(de)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Mehrkern-Mikrosphären mit verzögerter Wirkstoffabgabe und Verfahren zu deren Herstellung.
|
US5242910A
(en)
*
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5310742A
(en)
*
|
1992-11-30 |
1994-05-10 |
Elias Alan N |
Uses for thioureylenes
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
JPH06239746A
(ja)
*
|
1993-02-12 |
1994-08-30 |
Mayumi Okada |
モルヒネ徐放性製剤
|
JP3698721B2
(ja)
*
|
1993-02-23 |
2005-09-21 |
ジェネンテク・インコーポレイテッド |
有機溶媒を用いて処理したポリペプチドの賦形剤安定化
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5447725A
(en)
*
|
1993-06-11 |
1995-09-05 |
The Procter & Gamble Company |
Methods for aiding periodontal tissue regeneration
|
US5449663A
(en)
*
|
1993-06-11 |
1995-09-12 |
Bicher; Haim I. |
Antineoplastic compositions
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
CN1139380A
(zh)
*
|
1993-11-18 |
1997-01-01 |
癌症研究所 |
控释制剂
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
CA2143044C
(en)
*
|
1994-02-21 |
2005-04-12 |
Yasutaka Igari |
Matrix for sustained-release preparation
|
IE940292A1
(en)
*
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
US5538733A
(en)
*
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
CA2150060C
(en)
*
|
1994-07-08 |
2000-01-11 |
John T. Biggs |
Seamless multimedia conferencing system using enhanced endpoint devices
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5520923A
(en)
*
|
1994-09-19 |
1996-05-28 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
US5538737A
(en)
*
|
1994-11-30 |
1996-07-23 |
Applied Analytical Industries, Inc. |
Oral compositions of H2 -antagonists
|
DE4443175A1
(de)
*
|
1994-12-05 |
1996-06-13 |
Jenapharm Gmbh |
Neue pulsatile Arzneiform
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
CN1156961A
(zh)
|
1995-06-09 |
1997-08-13 |
欧罗赛铁克股份有限公司 |
产生长效局部麻醉的制剂和方法
|
EP0850051A2
(de)
*
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Mittel zur verzögerten freisetzung eines wirkstoffs
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
JP2000500744A
(ja)
|
1995-11-09 |
2000-01-25 |
マイクロバイオロジカル リサーチ オーソリティー |
ワクチン接種および遺伝子治療のためのマイクロカプセル化dna
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
CA2260750C
(en)
|
1996-06-24 |
2004-11-09 |
Euro-Celtique, S.A. |
Methods for providing safe local anesthesia
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7435425B2
(en)
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
EP0839525B1
(de)
*
|
1996-10-31 |
2004-08-04 |
Takeda Chemical Industries, Ltd. |
Zubereitung mit verzögerter Freisetzung
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5945126A
(en)
*
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
PL195763B1
(pl)
|
1997-06-30 |
2007-10-31 |
Monsanto Technology Llc |
Kompozycja do kontrolowanego uwalniania zapewniająca środek grzybobójczy roślinie i sposób wytwarzania kompozycji
|
IL129951A0
(en)
|
1997-07-02 |
2000-02-29 |
Euro Celtique Sa |
Prolonged anesthesia in joints and body spaces
|
US6391452B1
(en)
*
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
DE69841598D1
(de)
|
1997-09-18 |
2010-05-20 |
Pacira Pharmaceuticals Inc |
Retardierte freisetzung liposmaler anesthetischer zusammensetzungen.
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6045835A
(en)
*
|
1997-10-08 |
2000-04-04 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
US6106875A
(en)
*
|
1997-10-08 |
2000-08-22 |
Givaudan Roure (International) Sa |
Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
|
SE512663C2
(sv)
*
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
TW577758B
(en)
|
1997-10-27 |
2004-03-01 |
Ssp Co Ltd |
Intra-articular preparation for the treatment of arthropathy
|
JP4234803B2
(ja)
*
|
1997-10-27 |
2009-03-04 |
久光製薬株式会社 |
薬物放出速度が制御された医薬組成物
|
US20020039596A1
(en)
*
|
1997-11-14 |
2002-04-04 |
Hartoun Hartounian |
Production of multivesicular liposomes
|
CA2317039C
(en)
|
1998-01-21 |
2009-09-29 |
Takeda Chemical Industries, Ltd. |
Lyophilization method for sustained-release preparations
|
US20030180368A1
(en)
*
|
1998-03-14 |
2003-09-25 |
Cenes Drug Delivery Limited |
Production of microparticles
|
AP1224A
(en)
|
1998-03-19 |
2003-11-14 |
Bristol Myers Squibb Co |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US7128927B1
(en)
*
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
US6217844B1
(en)
*
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
US6451335B1
(en)
|
1998-07-02 |
2002-09-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
ATE428371T1
(de)
|
1998-07-17 |
2009-05-15 |
Pacira Pharmaceuticals Inc |
Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
|
US20070009605A1
(en)
*
|
1998-07-23 |
2007-01-11 |
Ignatious Francis X |
Encapsulation of water soluble peptides
|
US6200590B1
(en)
|
1998-08-10 |
2001-03-13 |
Naphcare, Inc. |
Controlled, phased-release suppository and its method of production
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
US6204308B1
(en)
|
1999-03-01 |
2001-03-20 |
Novartis Ag |
Organic compounds
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
US6709427B1
(en)
*
|
1999-08-05 |
2004-03-23 |
Kensey Nash Corporation |
Systems and methods for delivering agents into targeted tissue of a living being
|
AU6536400A
(en)
*
|
1999-08-11 |
2001-03-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
CN100387228C
(zh)
*
|
1999-08-27 |
2008-05-14 |
布鲁克伍德药品公司 |
可注射的美沙酮、部分类鸦片激动剂或类鸦片拮抗剂微粒组合物及其用途
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
EP1223990B1
(de)
|
1999-10-15 |
2004-07-28 |
Genetics Institute, LLC |
Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
|
US7651703B2
(en)
*
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US6682754B2
(en)
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US7771746B2
(en)
*
|
1999-12-03 |
2010-08-10 |
Polichem Sa |
Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
|
ES2169980B1
(es)
|
1999-12-17 |
2003-11-01 |
Lipotec Sa |
Microcapsulas para la liberacion prolongada de farmacos.
|
US6656467B2
(en)
*
|
2000-01-27 |
2003-12-02 |
Medimmune, Inc. |
Ultra high affinity neutralizing antibodies
|
TW200800298A
(en)
|
2000-01-27 |
2008-01-01 |
Zentaris Ag |
Compressed microparticles for dry injection
|
US6465425B1
(en)
*
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
ES2390761T3
(es)
|
2000-03-01 |
2012-11-16 |
Medimmune, Llc |
Anticuerpos recombinantes de alta potencia y método para producción de los mismos
|
US7153525B1
(en)
*
|
2000-03-22 |
2006-12-26 |
The University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
CN101305994A
(zh)
|
2000-04-26 |
2008-11-19 |
沃特森药物公司 |
最小化与奥昔布宁疗法有关的副作用
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US7029694B2
(en)
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US6589549B2
(en)
*
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US7018645B1
(en)
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
AR023940A1
(es)
*
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
CN1141974C
(zh)
*
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
CA2412899C
(en)
|
2000-07-05 |
2010-11-09 |
Takeda Chemical Industries, Ltd. |
Medicinal preparations for treating sex hormone-dependent diseases
|
PT1693054T
(pt)
*
|
2000-08-07 |
2016-07-07 |
Takeda Pharmaceuticals Co |
Polímero de ácido láctico e processo para a sua produção
|
FR2814380B1
(fr)
*
|
2000-09-25 |
2002-11-08 |
Serobiologiques Lab Sa |
Poudre de microcapsules et procede d'obtention
|
DE60138641D1
(de)
|
2000-10-27 |
2009-06-18 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
US8470359B2
(en)
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US7179900B2
(en)
*
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
EP1343480B2
(de)
|
2000-12-21 |
2016-02-17 |
Alrise Biosystems GmbH |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20030152637A1
(en)
*
|
2001-01-25 |
2003-08-14 |
Mark Chasin |
Local anesthetic, and method of use
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
FR2822834B1
(fr)
*
|
2001-04-02 |
2005-02-25 |
Flamel Tech Sa |
Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
|
WO2002094320A1
(fr)
|
2001-05-23 |
2002-11-28 |
Tanabe Seiyaku Co., Ltd. |
Compositions therapeutiques permettant de reparer la chondropathie
|
US20040146561A1
(en)
|
2001-05-23 |
2004-07-29 |
Naoki Sakurai |
Compositions for promoting healing of bone fracture
|
AU2002322024B2
(en)
*
|
2001-05-31 |
2008-05-08 |
Pacira Pharmaceuticals, Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
JP2004535431A
(ja)
*
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
AR034641A1
(es)
|
2001-06-29 |
2004-03-03 |
Takeda Pharmaceutical |
Composicion de liberacion controlada y metodo para producirla
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
CN1610551A
(zh)
*
|
2001-07-06 |
2005-04-27 |
恩德制药公司 |
用作止痛剂的6-羟基羟吗啡酮的肠胃外给药
|
ATE376832T1
(de)
*
|
2001-07-06 |
2007-11-15 |
Penwest Pharmaceuticals Co |
Verzögert freisetzende formulierungen von oxymorphon
|
EP1275378B1
(de)
|
2001-07-10 |
2009-04-15 |
Canon Kabushiki Kaisha |
Partikel auf Basis von Polyhydroxyalkanoat und Verfahren zu deren Herstellung
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
ATE395042T1
(de)
*
|
2001-08-16 |
2008-05-15 |
Baxter Int |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
DE60132094T3
(de)
*
|
2001-10-26 |
2012-02-02 |
Octoplus Polyactive Sciences B.V. |
Verfahren zur Herstellung von gereinigten Partikeln
|
EP1444988A4
(de)
|
2001-11-13 |
2007-04-25 |
Takeda Pharmaceutical |
Krebsmittel
|
KR20040058101A
(ko)
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
BR0206469A
(pt)
*
|
2001-11-14 |
2004-01-13 |
Alza Corp |
Composição injetável para depósito
|
EP2266590A3
(de)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
|
US20080213331A1
(en)
|
2002-04-08 |
2008-09-04 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
US7853333B2
(en)
|
2002-04-08 |
2010-12-14 |
Ardian, Inc. |
Methods and apparatus for multi-vessel renal neuromodulation
|
US8131371B2
(en)
|
2002-04-08 |
2012-03-06 |
Ardian, Inc. |
Methods and apparatus for monopolar renal neuromodulation
|
US7617005B2
(en)
|
2002-04-08 |
2009-11-10 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
US7620451B2
(en)
|
2005-12-29 |
2009-11-17 |
Ardian, Inc. |
Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
US20070135875A1
(en)
|
2002-04-08 |
2007-06-14 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
US8347891B2
(en)
|
2002-04-08 |
2013-01-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
|
US9308044B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
US8175711B2
(en)
|
2002-04-08 |
2012-05-08 |
Ardian, Inc. |
Methods for treating a condition or disease associated with cardio-renal function
|
US8150519B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods and apparatus for bilateral renal neuromodulation
|
US8774922B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
|
US9308043B2
(en)
|
2002-04-08 |
2016-04-12 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
US8145316B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
US20140018880A1
(en)
|
2002-04-08 |
2014-01-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
US7653438B2
(en)
|
2002-04-08 |
2010-01-26 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
US20070129761A1
(en)
|
2002-04-08 |
2007-06-07 |
Ardian, Inc. |
Methods for treating heart arrhythmia
|
US7162303B2
(en)
|
2002-04-08 |
2007-01-09 |
Ardian, Inc. |
Renal nerve stimulation method and apparatus for treatment of patients
|
US7756583B2
(en)
|
2002-04-08 |
2010-07-13 |
Ardian, Inc. |
Methods and apparatus for intravascularly-induced neuromodulation
|
US9636174B2
(en)
|
2002-04-08 |
2017-05-02 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
US8145317B2
(en)
|
2002-04-08 |
2012-03-27 |
Ardian, Inc. |
Methods for renal neuromodulation
|
US6978174B2
(en)
*
|
2002-04-08 |
2005-12-20 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
US7649023B2
(en)
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7166133B2
(en)
*
|
2002-06-13 |
2007-01-23 |
Kensey Nash Corporation |
Devices and methods for treating defects in the tissue of a living being
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
EP1532985B1
(de)
|
2002-06-25 |
2016-10-12 |
Takeda Pharmaceutical Company Limited |
Verfahren zur herstellung einer zusammensetzung mit verzögerter freisetzung
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
FR2843117B1
(fr)
|
2002-07-30 |
2004-10-15 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
|
ES2321505T3
(es)
|
2002-07-31 |
2009-06-08 |
Alza Corporation |
Composiciones de deposito de polimero multimodal inyectables y empleo de las mismas.
|
MXPA05001242A
(es)
|
2002-07-31 |
2005-06-08 |
Alza Corp |
Composiciones de deposito inyectable y usos de las mismas.
|
EP1549296A4
(de)
*
|
2002-08-02 |
2006-08-09 |
Penwest Pharmaceuticals Co |
Metformin-formulierungen mit verzögerter freisetzung
|
KR20120104412A
(ko)
|
2002-09-06 |
2012-09-20 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
US20060189554A1
(en)
*
|
2002-09-24 |
2006-08-24 |
Russell Mumper |
Nanoparticle-Based vaccine delivery system containing adjuvant
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
KR100709015B1
(ko)
*
|
2002-11-13 |
2007-04-18 |
(주)아모레퍼시픽 |
지속적 약물방출이 가능한 고분자 미립구 및 그 제조방법
|
WO2004043434A1
(en)
*
|
2002-11-14 |
2004-05-27 |
Shear/Kershman Laboratories, Inc. |
Oral testosterone delivery system with improved sustained release
|
WO2004060968A1
(fr)
*
|
2002-12-04 |
2004-07-22 |
Flamel Technologies |
Polyaminoacides fonctionnalises par au moins un groupement (oligo)aminoacide et leurs applications notamment therapeutiques
|
CA2510196C
(en)
|
2002-12-20 |
2014-04-01 |
Generipharm, Inc. |
Intracutaneous injection
|
CA2510320C
(en)
|
2002-12-20 |
2012-10-09 |
St. James Associates Llc/Faber Research Series |
Coated particles for sustained-release pharmaceutical administration
|
CA2553699A1
(en)
*
|
2003-02-11 |
2005-08-26 |
Venture Management Alliance, Llc |
Material incapsulation system
|
WO2004081196A2
(en)
*
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20060233883A1
(en)
*
|
2003-03-26 |
2006-10-19 |
Tsutomu Ishihara |
Intravenous nanoparticles for targeting drug delivery and sustained drug release
|
JP2006521366A
(ja)
*
|
2003-03-28 |
2006-09-21 |
シグモイド・バイオテクノロジーズ・リミテッド |
シームレスマイクロカプセルを含む固形経口剤形
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
FR2855521B1
(fr)
|
2003-05-28 |
2005-08-05 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
|
US8834864B2
(en)
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
ES2600554T3
(es)
|
2003-07-18 |
2017-02-09 |
Oakwood Laboratories L.L.C. |
Prevención de la reducción del peso molecular del polímero, de la formación de impurezas y de la gelificación en composiciones poliméricas
|
SG135204A1
(en)
*
|
2003-07-18 |
2007-09-28 |
Baxter Int |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
EP1646354A4
(de)
*
|
2003-07-22 |
2010-03-17 |
Baxter Int |
Kleine kugelförmige teilchen von niedermolekularen organischen molekülen und herstellungs- und anwendungsverfahren dafür
|
US20090214644A1
(en)
*
|
2003-07-31 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US20050025825A1
(en)
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
MEP3608A
(en)
|
2003-08-08 |
2011-05-10 |
Biovail Lab Int Srl |
Modified-release tablet of bupropion hydrochloride
|
US8153591B2
(en)
|
2003-08-26 |
2012-04-10 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
FR2860516B1
(fr)
*
|
2003-10-03 |
2006-01-13 |
Flamel Tech Sa |
Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
US20050101605A1
(en)
*
|
2003-11-07 |
2005-05-12 |
Ahmed Salah U. |
Oral liquid formulations of methotrexate
|
FR2862536B1
(fr)
*
|
2003-11-21 |
2007-11-23 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
DE602005013490D1
(de)
|
2004-02-23 |
2009-05-07 |
Euro Celtique Sa |
Missbrauchsichere transdermale abgabevorrichtung für opioide, enthaltend opioidantagonist in form von mikrokügelchen
|
US20050208134A1
(en)
*
|
2004-02-25 |
2005-09-22 |
Shlomo Magdassi |
Biocompatible polymeric beads and use thereof
|
US20050245614A1
(en)
*
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US7947739B2
(en)
|
2004-03-04 |
2011-05-24 |
Ferring B.V. |
Tranexamic acid formulations
|
US20050244495A1
(en)
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US8022106B2
(en)
*
|
2004-03-04 |
2011-09-20 |
Ferring B.V. |
Tranexamic acid formulations
|
US20090215898A1
(en)
*
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
WO2005094789A1
(ja)
*
|
2004-03-31 |
2005-10-13 |
Aspion Co., Ltd. |
S/o型製剤およびその製造方法
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
US20050260272A1
(en)
*
|
2004-05-05 |
2005-11-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
WO2005112893A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
EP1765294B1
(de)
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
WO2005112885A2
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
EP1768668A2
(de)
|
2004-06-16 |
2007-04-04 |
Tap Pharmaceutical Products, Inc. |
Multi-ppi-dosierform
|
US7740861B2
(en)
|
2004-06-16 |
2010-06-22 |
University Of Massachusetts |
Drug delivery product and methods
|
TW200613012A
(en)
*
|
2004-07-02 |
2006-05-01 |
Takeda Pharmaceuticals Co |
Sustained-release composition, process for producing the same and use of the same
|
EP2583717B1
(de)
|
2004-07-28 |
2019-02-20 |
Medtronic Ardian Luxembourg S.à.r.l. |
Verfahren und Vorrichtungen für die Nierennervenblockade
|
FR2873703B1
(fr)
*
|
2004-07-30 |
2006-12-08 |
Flamel Technologies Sa |
Polyaminoacides branches, fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
FR2873704B1
(fr)
*
|
2004-07-30 |
2006-12-08 |
Flamel Technologies Sa |
Polyaminoacides fonctionnalises par des greffons hydrophobes portant une charge anionique et leurs applications notamment therapeutiques
|
US20060040894A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Angiotech International Ag |
Compositions and methods using hyaluronic acid
|
WO2006025583A1
(ja)
*
|
2004-08-31 |
2006-03-09 |
Aspion Co., Ltd. |
S/o型外用剤
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
KR20070054246A
(ko)
|
2004-09-17 |
2007-05-28 |
유니버시티 오브 매사추세츠 |
리소좀성 효소 결핍을 위한 조성물 및 이의 용도
|
US20080020018A1
(en)
*
|
2004-09-27 |
2008-01-24 |
Joey Moodley |
Combination Products
|
CA2582374A1
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
ES2255426B1
(es)
|
2004-10-19 |
2007-08-16 |
Gp Pharm, S.A. |
Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
|
EP1812068A4
(de)
*
|
2004-10-29 |
2010-06-09 |
Medimmune Inc |
Verfahren zur prävention und behandlung von rsv-infektionen und verwandten leiden
|
US7937143B2
(en)
|
2004-11-02 |
2011-05-03 |
Ardian, Inc. |
Methods and apparatus for inducing controlled renal neuromodulation
|
DK1824460T3
(en)
*
|
2004-11-10 |
2015-01-19 |
Tolmar Therapeutics Inc |
Stabilized polymeric delivery system
|
ATE416349T1
(de)
*
|
2005-01-06 |
2008-12-15 |
Halton Oy |
Automatisches verschiebungsbelüftungssystem mit erhitzungsmodus
|
FR2881140B1
(fr)
*
|
2005-01-27 |
2007-04-06 |
Flamel Technologies Sa |
Copolyhydroxyalkylglutamines fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
|
EP1885335A1
(de)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Oberflächenmodifizierte mikroteilchen und verfahren zu ihrer bildung und verwendung
|
US8017152B2
(en)
|
2005-05-27 |
2011-09-13 |
Stratosphere Pharma Ab |
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
|
EP1726299A3
(de)
*
|
2005-05-27 |
2007-04-18 |
StratoSphere Pharma AB |
Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
|
CA2623507C
(en)
|
2005-09-19 |
2013-03-12 |
Neuronascent, Inc. |
Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
|
WO2007050643A2
(en)
*
|
2005-10-24 |
2007-05-03 |
University Of Massachusetts |
Compositions and their uses for gene therapy of bone conditions
|
FR2892725B1
(fr)
*
|
2005-10-31 |
2011-03-04 |
Flamel Tech Sa |
Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques
|
US20070106271A1
(en)
*
|
2005-11-09 |
2007-05-10 |
Searete Llc, A Limited Liability Corporation |
Remote control of substance delivery system
|
US20080286375A1
(en)
*
|
2005-11-15 |
2008-11-20 |
Amorepacific Corporation |
Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
|
US8546451B2
(en)
|
2005-11-28 |
2013-10-01 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US8637706B2
(en)
|
2005-11-28 |
2014-01-28 |
Gtx, Inc. |
Nuclear receptor binding agents
|
US9409856B2
(en)
|
2005-11-28 |
2016-08-09 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
WO2007067964A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Nastech Pharmaceutical Company Inc. |
Mucosal delivery of stabilized formulations of exendin
|
US8916206B2
(en)
*
|
2005-12-26 |
2014-12-23 |
Ltt Bio-Pharma Co., Ltd. |
Nanoparticles containing water-soluble non-peptide low-molecular weight drug
|
CU23388B6
(es)
|
2006-01-31 |
2009-07-16 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
|
KR100722607B1
(ko)
|
2006-05-11 |
2007-05-28 |
주식회사 펩트론 |
분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
|
US9023400B2
(en)
*
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
JP4720620B2
(ja)
*
|
2006-05-30 |
2011-07-13 |
コニカミノルタビジネステクノロジーズ株式会社 |
カール補正装置及びこれを備えた画像形成装置
|
WO2007137839A2
(en)
|
2006-05-31 |
2007-12-06 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
MX2009001226A
(es)
*
|
2006-08-04 |
2009-03-20 |
Baxter Int |
Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
|
AU2007319577A1
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter Healthcare S.A. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
JP5196760B2
(ja)
*
|
2006-10-27 |
2013-05-15 |
一般財団法人 九州医療資源財団 |
W/o/w型エマルジョン組成物
|
ES2663080T3
(es)
|
2006-11-01 |
2018-04-11 |
Ventana Medical Systems, Inc. |
Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
|
US9289196B2
(en)
|
2006-12-12 |
2016-03-22 |
Cook Medical Technologies Llc |
Hemostatic substance with a coating
|
MY148370A
(en)
|
2006-12-18 |
2013-04-15 |
Takeda Pharmaceutical |
Sustained-release composition and method for producing the same
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
CA2683415C
(en)
|
2007-04-04 |
2020-12-08 |
Sigmoid Pharma Limited |
An oral pharmaceutical composition
|
EP2586428B1
(de)
|
2007-04-26 |
2023-11-08 |
Sublimity Therapeutics Limited |
Herstellung mehrerer Minikapseln
|
EP2063875A2
(de)
*
|
2007-05-01 |
2009-06-03 |
Sigmoid Pharma Limited |
Pharmazeutische kombinationszusammensetzungen
|
FR2915748B1
(fr)
|
2007-05-03 |
2012-10-19 |
Flamel Tech Sa |
Acides polyglutamiques fonctionnalises par des groupes cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques
|
US20100129456A1
(en)
*
|
2007-05-14 |
2010-05-27 |
Ltt Bio-Pharma Co., Ltd. |
Sustained-release nanoparticle containing low-molecular-weight drug with negatively charged group
|
EP1997830A1
(de)
*
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
|
CA2693062C
(en)
|
2007-06-21 |
2016-08-09 |
Neuronascent, Inc. |
Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
|
US20080318994A1
(en)
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
US20080318993A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
|
US10011763B2
(en)
|
2007-07-25 |
2018-07-03 |
Schlumberger Technology Corporation |
Methods to deliver fluids on a well site with variable solids concentration from solid slurries
|
US9040468B2
(en)
|
2007-07-25 |
2015-05-26 |
Schlumberger Technology Corporation |
Hydrolyzable particle compositions, treatment fluids and methods
|
JP4526598B2
(ja)
*
|
2007-08-29 |
2010-08-18 |
祐徳薬品工業株式会社 |
乳化型外用剤およびその製造方法
|
RU2013106514A
(ru)
*
|
2007-10-12 |
2015-03-10 |
Такеда Фармасьютикалз Норт Америка, Инк. |
Способы лечения нарушений желудочно-кишечного тракта независимо от потребления пищи
|
CA2704056A1
(en)
*
|
2007-10-29 |
2009-05-07 |
University Of Massachusetts |
Encapsulated nanoparticles for nucleic acid delivery
|
EP2214734B1
(de)
|
2007-10-30 |
2017-12-13 |
Baxter International Inc. |
Verwendung einer regenerativen biofunktionalen kollagen-biomatrix zur behandlung von viszeralen oder parietalen defekten
|
EP2219775A4
(de)
*
|
2007-12-11 |
2012-10-03 |
Univ Nanyang Tech |
Mehrschichtige hohle mikrokügelchen für die freisetzung hydrophiler wirkstoffe
|
EP2237770A4
(de)
*
|
2007-12-26 |
2011-11-09 |
Gel Del Technologies Inc |
Biokompatible proteinteilchen, teilchenvorrichtungen und verfahren dafür
|
US8523569B2
(en)
*
|
2007-12-28 |
2013-09-03 |
Khashayar Kevin Neshat |
Controlled release local anesthetic for post dental surgery and method of use
|
US20090202642A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Xiao Huang |
Drug Delivery System Comprising Microparticles and Gelation System
|
WO2009105792A1
(en)
*
|
2008-02-18 |
2009-08-27 |
Csir |
Nanoparticle carriers for drug administration and process for producing same
|
JP5569398B2
(ja)
|
2008-02-29 |
2014-08-13 |
フェッローサン メディカル ディバイス エー/エス |
止血および/または創傷治癒を促進するための装置
|
KR100963435B1
(ko)
*
|
2008-06-19 |
2010-06-17 |
한국과학기술연구원 |
서방형 약물전달 및 조직재생용 덮인 다공성 생분해성고분자 미립구의 제조 방법
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
WO2010008582A2
(en)
|
2008-07-18 |
2010-01-21 |
Rxi Pharmaceuticals Corporation |
Phagocytic cell drug delivery system
|
US8034382B2
(en)
*
|
2008-07-31 |
2011-10-11 |
The Board Of Trustees Of The University Of Arkansas |
Preparation method for biodegradable micro-particles containing drugs
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100062057A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Pronova BioPharma Norge AS. |
Formulation
|
US10138485B2
(en)
|
2008-09-22 |
2018-11-27 |
Rxi Pharmaceuticals Corporation |
Neutral nanotransporters
|
AU2008363295B2
(en)
|
2008-10-20 |
2015-05-07 |
Forschungsverbund Berlin E.V. |
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
|
WO2010048302A1
(en)
|
2008-10-21 |
2010-04-29 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US8652129B2
(en)
|
2008-12-31 |
2014-02-18 |
Medtronic Ardian Luxembourg S.A.R.L. |
Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
|
WO2010078536A1
(en)
|
2009-01-05 |
2010-07-08 |
Rxi Pharmaceuticals Corporation |
Inhibition of pcsk9 through rnai
|
CA2749993C
(en)
*
|
2009-01-23 |
2016-12-20 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
US9745574B2
(en)
|
2009-02-04 |
2017-08-29 |
Rxi Pharmaceuticals Corporation |
RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
US9427418B2
(en)
|
2009-02-23 |
2016-08-30 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
US9624161B2
(en)
|
2009-02-23 |
2017-04-18 |
Gtx, Inc. |
Estrogen receptor ligands and methods of use thereof
|
JP6176894B2
(ja)
|
2009-03-09 |
2017-08-09 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用
|
WO2010129309A2
(en)
*
|
2009-04-27 |
2010-11-11 |
Premier Dental Products Compnay |
Microencapsulated compositions and methods for tissue mineralization
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
US20100280117A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Xanodyne Pharmaceuticals, Inc. |
Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
|
US9278070B2
(en)
|
2009-05-18 |
2016-03-08 |
Sigmoid Pharma Limited |
Composition comprising oil drops
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
KR101699992B1
(ko)
|
2009-06-16 |
2017-01-26 |
백스터 인터내셔널 인코포레이티드 |
지혈용 스펀지
|
GB2485327A
(en)
|
2009-08-12 |
2012-05-09 |
Sigmoid Pharma Ltd |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
GB0915480D0
(en)
*
|
2009-09-04 |
2009-10-07 |
Arecor Ltd |
Stable formulation of factor viii
|
EP2477985B1
(de)
|
2009-09-15 |
2018-11-07 |
BlueLink Pharmaceuticals, Inc. |
Crlx101 zur verwendung bei der krebsbehandlung
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
ES2364011B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
|
ES2363965B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm S.A. |
Cápsulas de principios activos betabloqueantes y ésteres de ácidos grasos poliinsaturados.
|
ES2363964B1
(es)
|
2009-11-20 |
2012-08-22 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
|
CN102781237A
(zh)
*
|
2009-11-23 |
2012-11-14 |
天蓝制药公司 |
用于传递治疗剂的基于环糊精的聚合物
|
AU2010339045B2
(en)
|
2009-12-16 |
2014-06-05 |
Baxter Healthcare S.A. |
Hemostatic sponge
|
KR20120104270A
(ko)
|
2009-12-23 |
2012-09-20 |
데피안떼 파마슈띠까 에스.에이. |
심혈관계 질환 치료에 유용한 복합 조성물
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
EP2353588B1
(de)
*
|
2010-01-21 |
2015-04-15 |
Agricultural Technology Research Institute |
Präparat mit verzögerter Freisetzung von Faktor IX
|
WO2011094426A1
(en)
|
2010-01-29 |
2011-08-04 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Caspase inhibitors
|
US9205577B2
(en)
*
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
WO2011112709A1
(en)
*
|
2010-03-09 |
2011-09-15 |
Elan Pharma International Limited |
Alcohol resistant enteric pharmaceutical compositions
|
EP3251506A1
(de)
|
2010-03-12 |
2017-12-06 |
Monsanto Technology LLC |
Agrochemische gel suzammensetzungen
|
CN101816910B
(zh)
*
|
2010-03-25 |
2011-12-07 |
陕西师范大学 |
固载十六烷基三甲基磷钨酸季铵盐杂化微凝胶的制备方法
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
JP5965387B2
(ja)
|
2010-04-08 |
2016-08-03 |
アメリカ合衆国 |
Tsh受容体用のインバースアゴニストおよびニュートラルアンタゴニスト
|
US11202853B2
(en)
*
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
CA2799202C
(en)
|
2010-05-18 |
2016-07-05 |
Cerulean Pharma Inc. |
Compositions and methods for treatment of autoimmune and other diseases
|
JP6289096B2
(ja)
|
2010-06-01 |
2018-03-07 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
乾燥した安定な止血組成物を作製するためのプロセス
|
CN103037847B
(zh)
|
2010-06-01 |
2016-01-20 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
US8940335B2
(en)
|
2010-06-01 |
2015-01-27 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
ES2385240B1
(es)
|
2010-07-26 |
2013-09-23 |
Gp-Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
|
US9242857B2
(en)
|
2010-08-14 |
2016-01-26 |
University Of Massachusetts |
Yeast cell wall particles for receptor-targeted nanoparticle delivery
|
GB201016433D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Apparatus and method for making solid beads
|
GB201016436D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Method of making solid beads
|
US9132291B2
(en)
|
2010-10-05 |
2015-09-15 |
Dfb Technology, Ltd. |
Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
|
JP6046041B2
(ja)
|
2010-10-25 |
2016-12-14 |
メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ |
神経変調療法の評価及びフィードバックのためのデバイス、システム、及び方法
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US8445032B2
(en)
|
2010-12-07 |
2013-05-21 |
Kimberly-Clark Worldwide, Inc. |
Melt-blended protein composition
|
US10821085B2
(en)
|
2010-12-07 |
2020-11-03 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical composition having antimicrobial properties
|
US9149045B2
(en)
|
2010-12-07 |
2015-10-06 |
Kimberly-Clark Worldwide, Inc. |
Wipe coated with a botanical emulsion having antimicrobial properties
|
US9832993B2
(en)
|
2010-12-07 |
2017-12-05 |
Kimberly-Clark Worldwide, Inc. |
Melt processed antimicrobial composition
|
US8524264B2
(en)
|
2010-12-07 |
2013-09-03 |
Kimberly-Clark Worldwide, Inc. |
Protein stabilized antimicrobial composition formed by melt processing
|
US9648874B2
(en)
|
2010-12-07 |
2017-05-16 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple use and re-use, user saturated wipes
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
US9446048B2
(en)
|
2011-03-17 |
2016-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
|
US20140348865A1
(en)
|
2011-09-12 |
2014-11-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Ser. |
Immunogens based on an hiv-1 v1v2 site-of-vulnerability
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
CN103957948B
(zh)
|
2011-10-11 |
2016-10-26 |
巴克斯特国际公司 |
止血组合物
|
CN103957949B
(zh)
|
2011-10-11 |
2017-07-18 |
巴克斯特国际公司 |
止血组合物
|
US9877929B2
(en)
|
2011-10-13 |
2018-01-30 |
Premier Dental Products Company |
Topical vitamin D and ubiquinol oral supplement compositions
|
KR101975624B1
(ko)
|
2011-10-27 |
2019-05-07 |
백스터 인터내셔널 인코포레이티드 |
지혈 조성물
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
US8574628B2
(en)
|
2011-12-19 |
2013-11-05 |
Kimberly-Clark Worldwide, Inc. |
Natural, multiple release and re-use compositions
|
US9249103B2
(en)
|
2012-01-13 |
2016-02-02 |
Oregon Health & Science University |
Compounds, compositions and associated methods comprising 3-aryl quinolines
|
EP2822474B1
(de)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Druckbehälter mit einer blutstillenden paste
|
US9510777B2
(en)
|
2012-03-08 |
2016-12-06 |
Medtronic Ardian Luxembourg S.A.R.L. |
Monitoring of neuromodulation using biomarkers
|
US9750568B2
(en)
|
2012-03-08 |
2017-09-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Ovarian neuromodulation and associated systems and methods
|
WO2013142608A1
(en)
*
|
2012-03-21 |
2013-09-26 |
Loma Linda University |
Substances and method for replacing natural tooth material
|
US9585896B2
(en)
|
2012-04-04 |
2017-03-07 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
|
WO2013150386A2
(en)
|
2012-04-04 |
2013-10-10 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
|
PT2858975T
(pt)
|
2012-06-08 |
2019-07-16 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Inibidores de fbxo3
|
AU2013275758B2
(en)
|
2012-06-12 |
2015-03-12 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
US9724542B2
(en)
|
2012-10-12 |
2017-08-08 |
Premier Dental Products Company |
Remineralizing and desensitizing compositions, treatments and methods of manufacture
|
US9877930B2
(en)
|
2012-10-12 |
2018-01-30 |
Premier Dental Products Company |
Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
|
US20140110296A1
(en)
|
2012-10-19 |
2014-04-24 |
Medtronic Ardian Luxembourg S.A.R.L. |
Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
|
EP2919779B1
(de)
|
2012-11-13 |
2021-01-06 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid rezeptor mediatoren
|
US20140142522A1
(en)
*
|
2012-11-16 |
2014-05-22 |
NU Technology, LLC |
Moist dressing with honeycomb pattern and drain channels
|
US9775895B2
(en)
|
2012-12-12 |
2017-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV therapeutics and methods of making and using same
|
MX2015011074A
(es)
|
2013-02-28 |
2016-03-09 |
Pronova Biopharma Norge As |
Composicion que comprende un compuesto lipido, un triglicerido y un tensioactivo, y metodos de uso de la misma.
|
KR101486132B1
(ko)
|
2013-03-20 |
2015-01-23 |
씨제이헬스케어 주식회사 |
졸-겔 변환 특성을 갖는 고분자를 이용한 미립구의 제조방법 및 이로부터 제조된 미립구
|
US9987233B2
(en)
|
2013-03-21 |
2018-06-05 |
Eupraxia Pharmaceuticals USA LLC |
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
|
KR101543507B1
(ko)
|
2013-05-15 |
2015-08-11 |
씨제이헬스케어 주식회사 |
연속 공정의 미립구의 제조 방법 및 이로부터 제조된 미립구
|
CA2912064A1
(en)
|
2013-05-16 |
2014-11-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of hiv-1 integrase
|
AU2014283170B2
(en)
|
2013-06-21 |
2017-11-02 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
BR112016002342A8
(pt)
|
2013-08-06 |
2018-01-23 |
Dong Kook Pharm Co Ltd |
microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
|
CN103432093B
(zh)
*
|
2013-08-31 |
2015-03-25 |
西南大学 |
甲磺酸普立地诺骨架缓释片及其制备方法
|
JP6564380B2
(ja)
|
2013-09-20 |
2019-08-21 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
前立腺癌を治療するための化合物
|
DK3054936T5
(da)
|
2013-10-10 |
2024-03-18 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
JP6489485B2
(ja)
|
2013-12-11 |
2019-03-27 |
フェロサン メディカル デバイシーズ エイ/エス |
押し出し増強因子を含んでいる乾燥組成物
|
US10398772B2
(en)
|
2014-01-08 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
|
US10194980B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
US10194979B1
(en)
|
2014-03-28 |
2019-02-05 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for catheter-based renal neuromodulation
|
US9980766B1
(en)
|
2014-03-28 |
2018-05-29 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and systems for renal neuromodulation
|
CN114191538A
(zh)
|
2014-03-31 |
2022-03-18 |
法尔玛赞公司 |
具有控释特征的装载肽的plga微球体的制备
|
US10329259B2
(en)
|
2014-05-09 |
2019-06-25 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Pyrazole derivatives and their use as cannabinoid receptor mediators
|
ES2914099T3
(es)
|
2014-08-25 |
2022-06-07 |
Salk Inst For Biological Studi |
Inhibidores novedosos de ULK1 y métodos de uso de los mismos
|
WO2016037154A1
(en)
|
2014-09-04 |
2016-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant hiv-1 envelope proteins and their use
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
US20160106804A1
(en)
*
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
KR20170102223A
(ko)
|
2014-11-07 |
2017-09-08 |
시그모이드 파마 리미티드 |
사이클로스포린을 포함하는 조성물
|
US10653837B2
(en)
|
2014-12-24 |
2020-05-19 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
WO2016103238A1
(en)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus f proteins and their use
|
WO2016112036A1
(en)
|
2015-01-05 |
2016-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
SG11201706729SA
(en)
|
2015-02-20 |
2017-09-28 |
Univ Oregon Health & Science |
Derivatives of sobetirome
|
US10017471B2
(en)
|
2015-04-21 |
2018-07-10 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10093613B2
(en)
|
2015-04-21 |
2018-10-09 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10035763B2
(en)
|
2015-04-21 |
2018-07-31 |
Gtx, Inc. |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
EP3286164A4
(de)
|
2015-04-21 |
2018-12-05 |
Gtx, Inc. |
Selektive liganden des androgenrezeptordegraders (sard) und verfahren zur verwendung davon
|
US10806720B2
(en)
|
2015-04-21 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10441570B2
(en)
|
2015-04-21 |
2019-10-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
|
JP2018513179A
(ja)
|
2015-04-21 |
2018-05-24 |
ジーティーエックス・インコーポレイテッド |
選択的アンドロゲン受容体分解剤(sard)リガンド及びその使用方法
|
US10865184B2
(en)
|
2015-04-21 |
2020-12-15 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US9834507B2
(en)
|
2015-04-21 |
2017-12-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US10654809B2
(en)
|
2016-06-10 |
2020-05-19 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
JP6784696B2
(ja)
|
2015-04-28 |
2020-11-11 |
プロノヴァ バイオファーマ ノルゲ エーエス |
硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び/又は治療のための使用
|
US20180273485A1
(en)
|
2015-06-04 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Cannabinoid receptor mediating compounds
|
US10918796B2
(en)
|
2015-07-03 |
2021-02-16 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
US10799580B2
(en)
|
2015-09-09 |
2020-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Expression vector delivery system and use thereof for inducing an immune response
|
EP3206672B1
(de)
|
2015-10-27 |
2018-03-14 |
Eupraxia Pharmaceuticals Inc. |
Retard-formulierungen von lokalanästhetika
|
US11464748B2
(en)
*
|
2016-02-01 |
2022-10-11 |
Emory University |
Particles for targeted delivery and uses in managing bleeding or blood clotting
|
EP3423448A1
(de)
|
2016-03-04 |
2019-01-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid-rezeptorvermittelnde verbindungen
|
EP3457851B1
(de)
|
2016-05-18 |
2021-06-23 |
Oregon Health & Science University |
Derivate von sobetirom
|
US10806719B2
(en)
|
2016-06-10 |
2020-10-20 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
US11230523B2
(en)
|
2016-06-10 |
2022-01-25 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
|
CA3024615A1
(en)
|
2016-06-10 |
2017-12-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (sard) ligands and methods of use thereof
|
US20190255079A1
(en)
|
2016-06-16 |
2019-08-22 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
EP3554538A2
(de)
|
2016-12-16 |
2019-10-23 |
Institute for Research in Biomedicine |
Neuartige rekombinante rsv-f-präfusionsproteine und verwendungen davon
|
US9962342B1
(en)
*
|
2017-03-14 |
2018-05-08 |
Sunny Pharmtech Inc. |
Pharmaceutical composition containing guaifenesin and application thereof
|
WO2019066649A1
(en)
|
2017-09-26 |
2019-04-04 |
Nanomi B.V. |
PROCESS FOR THE PREPARATION OF MICROPARTICLES BY A DOUBLE EMULSION TECHNIQUE
|
US11583497B2
(en)
|
2017-11-14 |
2023-02-21 |
The Schepens Eye Research Institute, Inc. |
Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
|
KR20200096791A
(ko)
|
2017-12-06 |
2020-08-13 |
바스프 에이에스 |
비알콜성 지방간염 치료용 지방산 유도체
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
CN110123634A
(zh)
|
2018-02-09 |
2019-08-16 |
株式会社理光 |
颗粒的制造方法,颗粒的制造装置,以及颗粒
|
CA3093551A1
(en)
|
2018-03-29 |
2019-10-03 |
Elex Biotech, Inc. |
Compounds for treatment of cardiac arrhythmias and heart failure
|
AU2019266529A1
(en)
|
2018-05-09 |
2020-12-03 |
Ethicon Inc. |
Method for preparing a haemostatic composition
|
US20210196678A1
(en)
|
2018-05-16 |
2021-07-01 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (sard) ligands and methods of use thereof
|
FR3082842A1
(fr)
|
2018-06-21 |
2019-12-27 |
Veru Inc. |
Polymorphe de cis-clomiphene (zuclomiphene) et procedes d'utilisation de celui-ci
|
US20220033387A1
(en)
|
2018-09-25 |
2022-02-03 |
The Usa, As Represented By The Secretary, Department Of Health And Human Services |
2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
|
EP3894383A1
(de)
|
2018-12-12 |
2021-10-20 |
Autobahn Therapeutics, Inc. |
Neuartige thyromimetika
|
CA3130371A1
(en)
|
2019-03-01 |
2020-09-10 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
WO2020185695A1
(en)
|
2019-03-11 |
2020-09-17 |
Oregon State University |
Analogues and derivatives of cephalotaxine and methods for making and using the compounds
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|
EP4192509A1
(de)
|
2020-08-05 |
2023-06-14 |
Ellipses Pharma Ltd |
Behandlung von krebs mit einem cyclodextrinhaltigen polymer-topoisomerase-inhibitor-konjugat und einem parp-inhibitor
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
AU2022288631A1
(en)
|
2021-06-09 |
2024-01-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023172751A1
(en)
|
2022-03-10 |
2023-09-14 |
University Of Massachusetts |
Devices and methods of treating wounds
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|